16142-09-9 Usage
Uses
Used in Pharmaceutical Synthesis:
(S)-2,6-DIAMINO-HEXANOIC ACID BENZYL ESTER DIHYDROCHLORIDE is used as an intermediate in the synthesis of pharmaceuticals for its ability to bind with other molecules, which can be crucial in the development of new drugs.
Used as a Chelating Agent:
In the field of medicine and biochemistry, (S)-2,6-DIAMINO-HEXANOIC ACID BENZYL ESTER DIHYDROCHLORIDE is used as a chelating agent to bind metal ions, which can be important for various applications such as detoxification processes or the stabilization of certain compounds in biological systems.
Used in Research and Development:
(S)-2,6-DIAMINO-HEXANOIC ACID BENZYL ESTER DIHYDROCHLORIDE is utilized in research and development for its potential to interact with other molecules, which can lead to the discovery of new biochemical pathways or the enhancement of existing pharmaceutical compounds.
Used in the Medical Industry:
In the medical industry, (S)-2,6-DIAMINO-HEXANOIC ACID BENZYL ESTER DIHYDROCHLORIDE is used as a component in the formulation of drugs that require its specific binding properties, potentially contributing to the treatment of various diseases and conditions.
Used in Biochemical Applications:
(S)-2,6-DIAMINO-HEXANOIC ACID BENZYL ESTER DIHYDROCHLORIDE is employed in biochemical applications for its ability to bind with metal ions and other molecules, which can be instrumental in understanding and manipulating biological processes at the molecular level.
Check Digit Verification of cas no
The CAS Registry Mumber 16142-09-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,4 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 16142-09:
(7*1)+(6*6)+(5*1)+(4*4)+(3*2)+(2*0)+(1*9)=79
79 % 10 = 9
So 16142-09-9 is a valid CAS Registry Number.
16142-09-9Relevant articles and documents
COMPOUND COMPRISING A NUCLEIC ACID AND A HALF-LIFE EXTENSION MOTIF
-
, (2021/06/04)
Disclosed herein are compounds including a nucleic acid (A), their preparation, and their use.
LIPID-MODIFIED NUCLEIC ACID COMPOUNDS AND METHODS
-
, (2019/12/25)
Disclosed herein, inter alia, are lipid-modified nucleic acid compounds of the following structure, their preparation, and their use: (I).